GALILEO: Aflibercept provides marked improvement in visual acuity in results from follow-up to 76 weeks

Article

Intravitreal injection of aflibercept provides marked improvement in visual acuity in treatment-naive eyes with macular edema secondary to central retinal vein occlusion in results from follow-up to 76 weeks in the phase III GALILEO study.

Recent Videos
EyeCon 2024: Laura M. Periman, MD, shares her passion for dry eye disease, discussing her surprising discovery of the Alpenglow Sign in Demodex blepharitis
David Eichenbaum, MD, presents advances in AMD therapy, highlights different mechanisms with a common goal
Related Content
Study examines navigation performance in glaucoma with virtual-reality-based assessment of path integration

Study examines navigation performance in glaucoma with virtual-reality-based assessment of path integration

Article
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy

Podcast
Study: Gene therapy effective in hereditary blindness

Study: Gene therapy effective in hereditary blindness

Article
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

Advancing the optimal diagnosis & treatment of thyroid eye disease

Podcast
ASRS offers a taste of Sweden

ASRS offers a taste of Sweden

Article
Treating meibomian gland dysfunction and glaucoma

Treating meibomian gland dysfunction and glaucoma

Article
© 2024 MJH Life Sciences

All rights reserved.